We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IAG:TSXiA Financial Corporation Inc. Analysis

Data as of 2026-03-14 - not real-time

CA$147.33

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

iA Financial is trading around $147, well below its 20‑day SMA of $154 and the 200‑day SMA of $157, signaling a potential bottom. The RSI of 29 places the stock in oversold territory, while the MACD remains bearish, suggesting short‑term momentum could still be weak. However, the DCF fair‑value estimate of roughly $825 and a calculated upside of over 20% imply the market is severely discounting the company's future cash flows.
Fundamentally, the firm posted a 33% revenue growth year‑over‑year, with healthy gross (46%) and operating (18%) margins, and generated over $2.3 bn of operating cash flow. A dividend yield of 2.63% backed by a modest 33% payout ratio, combined with a strong balance sheet (cash $2.5 bn vs debt $3.2 bn) points to sustainable shareholder returns. Notably, CEO Denis Ricard recently purchased 6,000 shares at $152, reinforcing confidence in the upside.
Risk‑wise, IAG exhibits a low beta (~0.68) and moderate 30‑day volatility (~38%), while volume trends are decreasing and the technical outlook is neutral. The insurance sector carries medium regulatory and geographic exposure (Canada/US), but currency risk is low given its primary CAD denomination and the stock enjoys sufficient liquidity on the TSX.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating potential rebound
  • Support level near $145 providing downside cushion
  • Insider buying signaling confidence

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • Strong revenue growth and cash generation
  • Sustainable dividend yield
  • Valuation upside still present but price may need time to adjust

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF‑derived fair value far above current price
  • Consistent earnings growth and margin stability
  • Durable dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth32.90%
Profit Margin12.04%
P/E Ratio13.0
ROE13.93%
ROA0.75%
Debt/Equity38.28
P/B Ratio1.9
Op. Cash FlowCA$2.3B
Free Cash FlowCA$2.1B
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI29.1
SupportCA$145.44
ResistanceCA$170.89
MA 20CA$153.89
MA 50CA$165.42
MA 200CA$157.34
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueCA$825.10
Target PriceCA$177.57
Upside/Downside20.53%
GradeUndervalued
TypeBlend
Dividend Yield2.63%

Risk Assessment

Beta0.68
Volatility38.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.